Our Successes

Below are some of the top whistleblower cases, in which we have successfully represented clients. We measure our success not only by the billions of stolen dollars that we have helped the government recover for taxpayers over the past twenty years – including through the largest False Claims Act case settlements in both 2017 and 2018 and the largest intervened FCA recovery in 2022 – but also by our track record in protecting public health and safety, bringing criminal wrongdoers to justice, preventing further fraud, and standing up for our clients who had the courage to bring illegal practices to light.

AmerisourceBergen Corp.
$885 million
Amgen Inc.
$762 million
Serono
$704 million
Mylan Inc.
$465 million
Mallinckrodt
$234 million

Our Successes

CleanSlate – $6 Million

CleanSlate, a nationwide chain of opioid treatment centers paid $6 million to partially settle a False Claims Act case.  The...
Read More >>

Athena – $18.25 Million

In January 2021, Athenahealth Inc. (Athena) settled two False Claims Act qui tam cases for $18.25 million. The settlements resolved...
Read More >>

Jewish Hospital – $10.1 Million

Jewish Hospital & St. Mary’s Healthcare, Inc., d/b/a Pharmacy Plus and Pharmacy Plus Specialty paid the United States over $10.1...
Read More >>

AmerisourceBergen Corp. — $885 Million

This landmark case was the largest False Claims Act recovery of 2018. AmerisourceBergen Corporation, one of the nation’s largest wholesale...
Read More >>

Mylan Inc. — $465 Million

This $465 million EpiPen® settlement among the United States, the States, and pharmaceutical companies Mylan Inc. and Mylan Specialty L.P....
Read More >>

Amgen Inc. — $762 Million

In the single largest criminal and civil fraud settlement against a biotechnology company, Amgen Inc. pled guilty to illegally introducing...
Read More >>

Amedisys, Inc. $150 Million Home Health Care Fraud Settlement

The largest home health care fraud settlement in the history of the False Claims Act was announced by the DOJ....
Read More >>

Serono, Inc. — $704 Million

Serono, Inc., the Swiss manufacturer of the AIDS treatment drug Serostim®, reached a then record settlement with the Department of...
Read More >>

WellCare Health Plans, Inc. — $217.5 Million

WellCare Health Plans (“WellCare”), a leading health management organization that provides or arranges for the provision of managed care services...
Read More >>